Cardiol Therapeutics Inc. Adjustments For Decrease Increase In Trade Account Receivable
Cardiol Therapeutics Inc. (CRDL) reported Adjustments For Decrease Increase In Trade Account Receivable of CAD 44.64 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2026-03-31
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|
| 2025-12-31 | 44.64K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 42.38K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 67.18K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | -144.18K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | -59.95K CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 5.87K CAD 20-F · filed 2023-03-29 |